{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:58:31Z","timestamp":1793055511927,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The study was supported by BIOGEN."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13023-017-0695-0","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T08:58:25Z","timestamp":1503046705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Social\/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain"],"prefix":"10.1186","volume":"12","author":[{"given":"Julio","family":"L\u00f3pez-Bastida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Mar\u00eda","family":"Pe\u00f1a-Longobardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Aranda-Reneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tizzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sefton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Oliva-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,18]]},"reference":[{"key":"695_CR1","doi-asserted-by":"crossref","unstructured":"Pearn J. Classification of spinal muscular atrophies. Lancet. 1980;1(8174):919\u201322.","DOI":"10.1016\/S0140-6736(80)90847-8"},{"key":"695_CR2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/cge.12222","volume":"85","author":"L Al\u00edas","year":"2014","unstructured":"Al\u00edas L, Barcel\u00f3 MJ, Bernal S, Mart\u00ednez-Hern\u00e1ndez R, Also-Rallo E, V\u00e1zquez C, Santana A, Mill\u00e1n JM, Baiget M, Tizzano EF. Improving detection and genetic counseling in carriers of spinal muscular atrophy with two copies of the SMN1 gene. Clin Genet. 2014;85:470\u20135.","journal-title":"Clin Genet"},{"issue":"Suppl 1","key":"695_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10198-016-0780-7","volume":"17","author":"J L\u00f3pez-Bastida","year":"2016","unstructured":"L\u00f3pez-Bastida J, Oliva-Moreno J, Linertov\u00e1 R, Serrano-Aguilar P. Social\/economic costs and health-related quality of life in patients with rare diseases in Europe. Eur J Health Econ. 2016;17(Suppl 1):1\u20135.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"695_CR4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-016-0424-0","volume":"11","author":"C Klug","year":"2016","unstructured":"Klug C, Schreiber-Katz O, Thiele S, Schorling E, Zowe J, Reilich P, Walter MC, Nagels KH. Disease burden of spinal muscular atrophy in Germany. Orphanet J Rare Dis. 2016 May 4;11(1):58.","journal-title":"Orphanet J Rare Dis"},{"issue":"9596","key":"695_CR5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Elm von","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"key":"695_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","volume":"2","author":"TL Munsat","year":"1992","unstructured":"Munsat TL, Davies KE. International SMA consortium meeting. Neuromuscul Disord. 1992;2:423\u20138.","journal-title":"Neuromuscul Disord"},{"key":"695_CR7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","volume":"52","author":"K Zerres","year":"1995","unstructured":"Zerres K, Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52:518\u201323.","journal-title":"Arch Neurol"},{"issue":"9","key":"695_CR8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","volume":"83","author":"RS Finkel","year":"2014","unstructured":"Finkel RS, McDermott MP, Kaufmann P, et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology. 2014 Aug 26;83(9):810\u20137.","journal-title":"Neurology"},{"issue":"2","key":"695_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.nmd.2015.10.006","volume":"26","author":"E Mercuri","year":"2016","unstructured":"Mercuri E, Finkel R, Montes J, et al. Patterns ofdisease progression in type 2 and 3 SMA: implications for clinical trials. Neuromuscul Disord. 2016 Feb;26(2):126\u201331. doi:\n10.1016\/j.nmd.2015.10.006\n\n.","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"695_CR10","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1212\/01.wnl.0000249311.80411.93","volume":"67","author":"J Lopez-Bastida","year":"2006","unstructured":"Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands. Spain Neurology. 2006;67(12):2186\u201391.","journal-title":"Spain Neurology"},{"key":"695_CR11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mds.21798","volume":"23","author":"J Lopez-Bastida","year":"2008","unstructured":"Lopez-Bastida J, Monton-Alvarez F, Serrano-Aguilar P, Perestelo-Perez L, et al. Mov Disord. 2008;23:212\u20137.","journal-title":"Mov Disord"},{"issue":"4","key":"695_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/17482960802430781","volume":"10","author":"J L\u00f3pez-Bastida","year":"2009","unstructured":"L\u00f3pez-Bastida J, Perestelo-P\u00e9rez L, Mont\u00f3n-Alvarez F, Serrano-Aguilar P, Alfonso-Sanchez JL. Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain. Amyotroph Lateral Scler. 2009 Aug;10(4):237\u201343.","journal-title":"Amyotroph Lateral Scler"},{"issue":"3","key":"695_CR13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/acr.22167","volume":"66","author":"J L\u00f3pez-Bastida","year":"2014","unstructured":"L\u00f3pez-Bastida J, Linertov\u00e1 R, Oliva-Moreno J, Posada-de-la-Paz M, Serrano-Aguilar P. Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain. Arthritis Care Res. 2014;66(3):473\u201380.","journal-title":"Arthritis Care Res"},{"key":"695_CR14","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Costes por GRD. Available at: \nhttp:\/\/www.msssi.gob.es\/estadEstudios\/estadisticas\/inforRecopilaciones\/anaDesarrolloGDR.htm\n\n. Accessed Apr 2016."},{"key":"695_CR15","unstructured":"Instituto de Mayores y Servicios Sociales (IMSERSO). Ministerio de Sanidad, Servicios Sociales e Igualdad. Available at: \nhttp:\/\/www.imserso.es\/imserso_01\/el_inserso\/index.htm\n\n. Accessed Apr 2016."},{"key":"695_CR16","unstructured":"Vademecum. Gu\u00eda Farmacol\u00f3gica. 2016. Available at: \nhttps:\/\/www.vademecum.es\/productos-vademecum-guia+farmacologica-3\n\n. Accessed Apr 2016."},{"key":"695_CR17","unstructured":"Agencia Espa\u00f1ola del Medicamentos y productos sanitarios. Available at: \nhttps:\/\/www.aemps.gob.es\n\n. Accessed Apr 2016."},{"key":"695_CR18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40273-013-0104-z","volume":"31","author":"RJ Hoefman","year":"2013","unstructured":"Hoefman RJ, van Exel J, Brouwer W. How to include informal care in economic evaluations. PharmacoEconomics. 2013;31:1105\u201319.","journal-title":"PharmacoEconomics"},{"key":"695_CR19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hec.1075","volume":"15","author":"B Berg van den","year":"2006","unstructured":"van den Berg B, Spauwen P. Measurement of informal care: an empirical study into the valid measurement of time spent on informal caregiving. Health Econ. 2006;15:447\u201360.","journal-title":"Health Econ"},{"key":"695_CR20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.socscimed.2005.06.046","volume":"62","author":"B Berg van den","year":"2006","unstructured":"van den Berg B, Brouwer W, van Exel J, Koopmanschap M, van den Bos G, Rutten F. Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods. Soc Sci Med. 2006;62:835\u201345.","journal-title":"Soc Sci Med"},{"key":"695_CR21","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Bastida J, Linertov\u00e1 R, Oliva-Moreno J, Posada-de-la-Paz M, Serrano-Aguilar P, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Baji P, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network. Social\/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe. Eur J Health Econ. 2016;17(Suppl 1):99\u2013108.\u00a0","DOI":"10.1007\/s10198-016-0788-z"},{"key":"695_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53\u201372.","journal-title":"Health Policy"},{"key":"695_CR23","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"1997","unstructured":"Drummond MF, O\u2019Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press; 1997.","edition":"2"},{"issue":"1","key":"695_CR24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(1):1095\u2013108.","journal-title":"Med Care"},{"key":"695_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1008923029886","volume":"9","author":"EA Stolk","year":"2000","unstructured":"Stolk EA, Busschbach JJ, Vogels T, et al. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2000;9:29\u201338.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"695_CR26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0266462309990171","volume":"25","author":"DCM Willems","year":"2009","unstructured":"Willems DCM, Joore MA, Nieman FHM, Severens JL, Wouters EFM, Hendriks JJE. Using EQ-5D in children with asthma, rheumatic disorders, diabetes, and speech\/language and\/or hearing disorders. Int J Technol Assess Health Care. 2009;25:391\u20139.","journal-title":"Int J Technol Assess Health Care"},{"key":"695_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0272989X04273140","volume":"25","author":"K Secnik","year":"2005","unstructured":"Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S. Health state utilities for childhood attention-deficit\/hyperactivity disorder based on parent preferences in the United kingdom. Med Decis Mak. 2005;25:56\u201370.","journal-title":"Med Decis Mak"},{"issue":"8","key":"695_CR28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00019053-200523080-00004","volume":"23","author":"LS Matza","year":"2005","unstructured":"Matza LS, Secnik K, Mannix S, Sallee FR. Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK. PharmacoEconomics. 2005;23(8):777\u201390.","journal-title":"PharmacoEconomics"},{"key":"695_CR29","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med. 1965;14:61\u20135.","journal-title":"Md State Med"},{"key":"695_CR30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0895-4356(89)90065-6","volume":"42","author":"S Shah","year":"1989","unstructured":"Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel index for stroke rehabilitation. J Clin Epidemiol. 1989;42:703\u20139.","journal-title":"J Clin Epidemiol"},{"key":"695_CR31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/S1135-57271997000200004","volume":"71","author":"CJ Ruzafa","year":"1997","unstructured":"Ruzafa CJ, Damian Moreno J. Valoracion de la discapacidad fisica: el Indice de Barthel. Rev Esp Salud P\u00fablica. 1997;71:127\u201337.","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"695_CR32","doi-asserted-by":"crossref","unstructured":"H\u00e9rbert R, Bravo G, Pr\u00e9ville M. Reliability, validity, and reference values of the Zarit burden interview for assessing informal caregivers of community-dwelling older persons with dementia. Can JAging. 2000:494\u2013507.","DOI":"10.1017\/S0714980800012484"},{"key":"695_CR33","volume-title":"Impact of glycemic control and diabetic complications or comorbidities on health related quality of life in pediatric patients with type 1 diabetes mellitus and their caregivers in Spain","author":"LA V\u00e1zquez","year":"2016","unstructured":"V\u00e1zquez LA, L\u00f3pez-Bastida J, Perez-Nieves M, Oliva-Moreno J, Villoro R, Dilla T, Merino M, Sapin H, Aranda I, Reviriego J, L\u00f3pez-Siguero JP. Impact of glycemic control and diabetic complications or comorbidities on health related quality of life in pediatric patients with type 1 diabetes mellitus and their caregivers in Spain. Valencia: 42nd Annual Conference of the International Society for Pediatric and Adolescent Diabetes; 2016. ISPAD 2016 October 26 \u2013 29"},{"key":"695_CR34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1186\/1471-2458-10-675","volume":"10","author":"J Oliva-Moreno","year":"2010","unstructured":"Oliva-Moreno J, Lopez-Bastida J, Worbes-Cerezo M, Serrano-Aguilar P. Health related quality of life of Canary Islands citizens: combining a general health survey and observational studies. BMC Public Health. 2010;10:675\u201383.","journal-title":"BMC Public Health"},{"key":"695_CR35","doi-asserted-by":"crossref","unstructured":"Alvarez-Sab\u00edn J, Quintana M, Masjuan J, Oliva-Moreno J, Mar J, Gonzalez-Rojas N, Becerra V, Torres C, Yebenes M. CONOCES investigators group. Economic impact of patients admitted to stroke units in Spain: Eur J Health Econ. 2017;18(4):449\u2013458.","DOI":"10.1007\/s10198-016-0799-9"},{"issue":"8","key":"695_CR36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.recesp.2013.12.016","volume":"67","author":"JF Delgado","year":"2014","unstructured":"Delgado JF, Oliva J, Llano M, Pascual-Figal D, Grillo JJ, Com\u00edn-Colet J, D\u00edaz B, Mart\u00ednez de La Concha L, Mart\u00ed B, Pe\u00f1a LM. Health care and non-health care costs in the treatment of patients with symptomatic chronic heart failure in Spain. Rev Esp Cardiol (Engl Ed). 2014;67(8):643\u201350.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"695_CR37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13561-014-0015-5","volume":"4","author":"M Trapero-Bertran","year":"2014","unstructured":"Trapero-Bertran M, Oliva J. Economic burden of HIV\/AIDS in the European context. Heal Econ Rev. 2014;4:15.","journal-title":"Heal Econ Rev"},{"issue":"Suppl 1","key":"695_CR38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10198-016-0784-3","volume":"17","author":"K Chevreul","year":"2016","unstructured":"Chevreul K, Gandr\u00e9 C, Brigham KB, L\u00f3pez-Bastida J, Linertov\u00e1 R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, Gul\u00e1csi L, von der Schulenburg JM, Kanavos P, Persson U, Fattore G. BURQOL-RD research network. Social\/economic costs and health-related quality of life in patients with fragile X syndrome in Europe. Eur J Health Econ. 2016;17(Suppl 1):43\u201352.","journal-title":"Eur J Health Econ"},{"issue":"Suppl 1","key":"695_CR39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10198-016-0782-5","volume":"17","author":"M Cavazza","year":"2016","unstructured":"Cavazza M, Kodra Y, Armeni P, De Santis M, L\u00f3pez-Bastida J, Linertov\u00e1 R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, P\u00e9ntek M, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G, et al. Eur J Health Econ. 2016;17(Suppl 1):19\u201329.","journal-title":"Eur J Health Econ"},{"key":"695_CR40","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s11136-015-0971-1","volume":"24","author":"P Kind","year":"2015","unstructured":"Kind P, Klose K, Gusi N, Olivares PR, Greiner W. Can adult weights be used to value child health states? Testing the influence of perspective in valuing EQ-5D-Y. Qual Life Res. 2015;24:2519\u201339.","journal-title":"Qual Life Res"},{"issue":"3","key":"695_CR41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40273-016-0468-y","volume":"35","author":"J Oliva-Moreno","year":"2017","unstructured":"Oliva-Moreno J, Trapero-Bertran M, Pe\u00f1a-Longobardo LM, del Pozo-Rubio R. The valuation of informal care in cost-of-illness studies: a systematic review. PharmacoEconomics. 2017;35(3):331\u201345.","journal-title":"PharmacoEconomics"},{"key":"695_CR42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12883-015-0473-3","volume":"15","author":"Y Qian","year":"2015","unstructured":"Qian Y, McGraw S, Henne J, et al. Understanding the experiences and needs of individuals with spinal muscular atrophy and their parents: a qualitative study. BMC Neurol. 2015;15:217.","journal-title":"BMC Neurol"},{"key":"695_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-199202010-00001","volume":"2","author":"M Drummond","year":"1992","unstructured":"Drummond M. Cost-of-illness studies: a major headache? PharmacoEconomics. 1992;2:1\u20134.","journal-title":"PharmacoEconomics"},{"key":"695_CR44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10198-008-0135-0","volume":"10","author":"J Oliva","year":"2009","unstructured":"Oliva J, Lopez-Bastida J, Montejo AL, Osuna R, Duque B. The socioeconomic costs of mental illness in Spain. Eur J Health Econ. 2009;10:361\u20139.","journal-title":"Eur J Health Econ"},{"key":"695_CR45","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","volume":"86","author":"CA Chiriboga","year":"2016","unstructured":"Chiriboga CA, Swoboda KJ, Darras BT, Iannaccone ST, Montes J, De Vivo DC, Norris DA, Bennett CF, Bishop KM. Results from a phase 1 study of nusinerse (ISIS-SMN (Rx)) in children with spinal muscular atrophy. Neurology. 2016;86:890\u20137. doi: 10.1212PMC4782111","journal-title":"Neurology"},{"issue":"3","key":"695_CR46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, Le TT, Morales PR, Rich MM, Burghes AH, Kaspar BK. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol. 2010;28(3):271\u20134.","journal-title":"Nat Biotechnol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T08:58:51Z","timestamp":1503046731000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,18]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0695-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,18]]},"article-number":"141"}}